TransMed7
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
117 Solana Rd, Portola Valley, Californi...Phone Number
(650) 400-0101Website
www.transmed7.comRevenue
$6.1 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About TransMed7
TransMed7, LLC is a privately-held medical technology company that specializes in developing innovative, cost-effective, minimally invasive medical devices for various healthcare fields. Their flagship product, the Zero5 biopsy device, offers advanced solutions for breast health, soft tissue surgery, and other medical applications, emphasizing accuracy and minimal tissue damage. The company targets healthcare providers and professionals in oncology, regenerative medicine, and cardiovascular disease, aiming to enhance patient care through their transformative technologies. Founded in 2010, TransMed7 is committed to addressing critical healthcare needs with a focus on affordability and accessibility worldwide.Explore more
TransMed7 Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is TransMed7 your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when TransMed7 launches new products
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on TransMed7 recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
TransMed7, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if TransMed7 had a recent Job posting/layoffs
Check if TransMed7 has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at TransMed7
Funding: Get notified immidiatlly once TransMed7 has new funding data
Check out if TransMed7 is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined TransMed7 as Masked Content
Find more new buyers
Compare Similar Companies to TransMed7
Compare insights from companies similar to TransMed7, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
TransMed7 is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
TransMed7 is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about TransMed7.
TransMed7 Tech Stack
A closer look at the technologies used by TransMed7
TransMed7 News & Media
TransMed7, LLC Announces First Clinical Use of VacuPac®, a New Self-Contained, Vacuum-Assist Attachment for all of its Vacuum-Assisted, Single Insertion - Multiple Collection (SIMC®) Platforms of Biopsy Devices
PORTOLA VALLEY, Calif.--(BUSINESS WIRE)--TransMed7, LLC announced today the first clinical use of VacuPac®, a new self-contained external vacuum-assist attachment with a SpeedBird Universal and a Concorde US from the SpeedBird and Concorde families of vacuum-assisted, Single Insertion – Multiple Collection (SIMC® ) breast biopsy devices. This follows the announcements in August 2022 and February 2023 of the first clinical uses of SpeedBird and Concorde biopsy devices, as part of the commercialTransMed7, LLC Announces First Clinical Cases of Concorde Soft Tissue Biopsy Devices for Commercial Launch
PORTOLA VALLEY, Calif.--(BUSINESS WIRE)--TransMed7, LLC Announces First Clinical Cases of Concorde Soft Tissue Biopsy devices for Commercial Launch.TransMed7, LLC Announces First Clinical Use of Heron Soft Tissue Biopsy Devices for Commercial Launch
PORTOLA VALLEY, Calif.--(BUSINESS WIRE)--TransMed7, LLC announced today that the “First in Human” clinical case of the commercial production version of a Heron™ XPS device (a member of the new Heron™ family of vacuum-assisted, Single Insertion / Multiple Collection (SIMC®) Soft Tissue Biopsy devices) was successfully performed by Dr. Edgar Staren, a surgical oncologist with the US Oncology network and a Clinical Professor of Surgery at the University of Arizona Phoenix, College of Medicine. Dr.TransMed7, LLC Announces First Clinical Use of SpeedBird™ Breast Biopsy Devices for Commercial Launch
PORTOLA VALLEY, Calif.--(BUSINESS WIRE)--TransMed7, LLC announced today that the first clinical cases of the final commercial production version of the Sparrow device (a member of the new SpeedBird™ family of vacuum-assisted, Single Insertion / Multiple Collection (SIMC®) Breast Biopsy devices) were successfully performed by Dr. Edgar Staren, a distinguished surgeon and former President of the American Society of Breast Surgeons (ASBrS). Dr. Staren commented, “Image-guided breast biopsy using T
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding TransMed7
Sign Up For FreeTo access detailed company insights
TransMed7, LLC is a privately-held medical technology company that specializes in developing innovative, cost-effective, minimally invasive medical devices for various healthcare fields. Their flagship product, the Zero5 biopsy device, offers advanced solutions for breast health, soft tissue surgery, and other medical applications, emphasizing accu... Read More
